The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

Multiple sclerosis (MS) is a progressive immune-related disorder of the central nervous system leading to destruction of myelin sheaths. Natalizumab is a humanized monoclonal antibody against the cell adhesion...
Source: Clinical and Translational Medicine - Category: Internal Medicine Authors: Tags: Research Source Type: research